Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Bagaev

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2018
Anticancer Mechanisms in Two Murine Bone Marrow-Derived Dendritic Cell Subsets Activated with TLR4 AgonistsAlexander Bagaev, Aleksey Pichugin, Edward L Nelson, et al.
BMC Immunology|July 30, 2018
The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vectorEkaterina Lebedeva, Alexander Bagaev, Alexey Pichugin, et al.
Clinical & Experimental Metastasis|October 8, 2013
Primary 4T1 tumor resection provides critical "window of opportunity" for immunotherapyAnahit Ghochikyan, Arpine Davtyan, Armine Hovakimyan, et al.
Frontiers in Oncology|July 31, 2025
Machine learning-based single-sample molecular classifier for cancer gradingZoia Antysheva, Nikita Kotlov, Mariia V Guryleva, et al.
Plos One|January 30, 2018
Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hostsIrina Tutykhina, Ilias Esmagambetov, Alexander Bagaev, et al.
Clinical Genitourinary Cancer|August 14, 2021
Diagnostic Utility of RNA-Seq for Evaluation of PD-L1 Expression in Clear Cell Renal Cell CarcinomaMaria Sorokina, Danil Stupichev, Yang Lyu, et al.
Human Genetics|December 2, 2025
MutAnt: mutation annotation tool predicts deleteriousness of missense mutations and improves mutation calling from transcriptomicsAleksandr Sarachakov, Anastasiya Yudina, Viktor Svekolkin, et al.
Cancer Cell|May 21, 2021
Conserved pan-cancer microenvironment subtypes predict response to immunotherapyAlexander Bagaev, Nikita Kotlov, Krystle Nomie, et al.
JCO Precision Oncology|May 6, 2026
Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung CancerDhruv Bansal, Ben Ponvilawan, Dmitrii Grachev, et al.
Blood Cancer Journal|October 11, 2023
Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphomaPreetesh Jain, Krystle Nomie, Nikita Kotlov, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2018
Anticancer Mechanisms in Two Murine Bone Marrow-Derived Dendritic Cell Subsets Activated with TLR4 AgonistsAlexander Bagaev, Aleksey Pichugin, Edward L Nelson, et al.
BMC Immunology|July 30, 2018
The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vectorEkaterina Lebedeva, Alexander Bagaev, Alexey Pichugin, et al.
Clinical & Experimental Metastasis|October 8, 2013
Primary 4T1 tumor resection provides critical "window of opportunity" for immunotherapyAnahit Ghochikyan, Arpine Davtyan, Armine Hovakimyan, et al.
Frontiers in Oncology|July 31, 2025
Machine learning-based single-sample molecular classifier for cancer gradingZoia Antysheva, Nikita Kotlov, Mariia V Guryleva, et al.
Plos One|January 30, 2018
Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hostsIrina Tutykhina, Ilias Esmagambetov, Alexander Bagaev, et al.
Clinical Genitourinary Cancer|August 14, 2021
Diagnostic Utility of RNA-Seq for Evaluation of PD-L1 Expression in Clear Cell Renal Cell CarcinomaMaria Sorokina, Danil Stupichev, Yang Lyu, et al.
Human Genetics|December 2, 2025
MutAnt: mutation annotation tool predicts deleteriousness of missense mutations and improves mutation calling from transcriptomicsAleksandr Sarachakov, Anastasiya Yudina, Viktor Svekolkin, et al.
Cancer Cell|May 21, 2021
Conserved pan-cancer microenvironment subtypes predict response to immunotherapyAlexander Bagaev, Nikita Kotlov, Krystle Nomie, et al.
JCO Precision Oncology|May 6, 2026
Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung CancerDhruv Bansal, Ben Ponvilawan, Dmitrii Grachev, et al.
Blood Cancer Journal|October 11, 2023
Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphomaPreetesh Jain, Krystle Nomie, Nikita Kotlov, et al.
Pageof 4